The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-(+)-ethyl 5-amino 2-methyl-1,2-dihydro-3-phenylpyrido[3,4-b]pyrazin-7-yl carbamate ID: ALA4532022
PubChem CID: 155546464
Max Phase: Preclinical
Molecular Formula: C17H19N5O2
Molecular Weight: 325.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCNC(=O)Oc1cc2c(c(N)n1)N=C(c1ccccc1)[C@@H](C)N2
Standard InChI: InChI=1S/C17H19N5O2/c1-3-19-17(23)24-13-9-12-15(16(18)21-13)22-14(10(2)20-12)11-7-5-4-6-8-11/h4-10,20H,3H2,1-2H3,(H2,18,21)(H,19,23)/t10-/m1/s1
Standard InChI Key: KJJNVMQPVNUKDX-SNVBAGLBSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
16.9447 -19.5552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2397 -19.9638 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.9447 -18.7380 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.6537 -19.9638 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7769 -18.7380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7769 -19.5552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4860 -18.3294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4860 -19.9638 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1909 -19.5552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1909 -18.7380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0678 -18.3294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0678 -19.9638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3587 -19.5552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3587 -18.7380 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9000 -18.3294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9000 -17.5122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6050 -17.1036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3141 -17.5122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3141 -18.3294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6050 -18.7380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9000 -19.9638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0678 -17.5122 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5306 -19.5552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8215 -19.9638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
1 4 1 0
5 6 2 0
5 7 1 0
6 8 1 0
8 9 1 0
9 10 1 0
7 10 2 0
12 13 2 0
13 14 1 0
11 14 2 0
5 11 1 0
6 12 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
10 15 1 0
9 21 1 1
11 22 1 0
4 13 1 0
23 24 1 0
2 23 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 325.37Molecular Weight (Monoisotopic): 325.1539AlogP: 2.71#Rotatable Bonds: 3Polar Surface Area: 101.63Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.53CX LogP: 2.43CX LogD: 2.07Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.81Np Likeness Score: -0.39
References 1. Bueno O, Gargantilla M, Estévez-Gallego J, Martins S, Díaz JF, Camarasa MJ, Liekens S, Pérez-Pérez MJ, Priego EM.. (2019) Diphenyl ether derivatives occupy the expanded binding site of cyclohexanedione compounds at the colchicine site in tubulin by movement of the αT5 loop., 171 [PMID:30921759 ] [10.1016/j.ejmech.2019.03.045 ]